GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (OTCPK:CZMWF) » Definitions » 12-1 Month Momentum %

Carl Zeiss Meditec AG (Carl Zeiss Meditec AG) 12-1 Month Momentum % : -6.38% (As of Apr. 29, 2024)


View and export this data going back to . Start your Free Trial

What is Carl Zeiss Meditec AG 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-04-29), Carl Zeiss Meditec AG's 12-1 Month Momentum % is -6.38%.

The industry rank for Carl Zeiss Meditec AG's 12-1 Month Momentum % or its related term are showing as below:

CZMWF's 12-1 Month Momentum % is ranked better than
65.02% of 852 companies
in the Medical Devices & Instruments industry
Industry Median: -17.415 vs CZMWF: -6.38

Competitive Comparison of Carl Zeiss Meditec AG's 12-1 Month Momentum %

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carl Zeiss Meditec AG's 12-1 Month Momentum % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's 12-1 Month Momentum % falls into.



Carl Zeiss Meditec AG  (OTCPK:CZMWF) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Carl Zeiss Meditec AG  (OTCPK:CZMWF) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Carl Zeiss Meditec AG 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Carl Zeiss Meditec AG (Carl Zeiss Meditec AG) Business Description

Address
Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: Ophthalmic devices and Microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.